1. Home
  2. AMPH vs VRE Comparison

AMPH vs VRE Comparison

Compare AMPH & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • VRE
  • Stock Information
  • Founded
  • AMPH 1996
  • VRE 1949
  • Country
  • AMPH United States
  • VRE United States
  • Employees
  • AMPH N/A
  • VRE N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • VRE Real Estate Investment Trusts
  • Sector
  • AMPH Health Care
  • VRE Real Estate
  • Exchange
  • AMPH Nasdaq
  • VRE Nasdaq
  • Market Cap
  • AMPH 1.2B
  • VRE 1.4B
  • IPO Year
  • AMPH 2014
  • VRE 1994
  • Fundamental
  • Price
  • AMPH $24.39
  • VRE $15.09
  • Analyst Decision
  • AMPH Buy
  • VRE Buy
  • Analyst Count
  • AMPH 6
  • VRE 5
  • Target Price
  • AMPH $35.50
  • VRE $19.20
  • AVG Volume (30 Days)
  • AMPH 369.0K
  • VRE 597.5K
  • Earning Date
  • AMPH 11-06-2025
  • VRE 10-22-2025
  • Dividend Yield
  • AMPH N/A
  • VRE 2.12%
  • EPS Growth
  • AMPH N/A
  • VRE N/A
  • EPS
  • AMPH 2.68
  • VRE 0.68
  • Revenue
  • AMPH $722,679,000.00
  • VRE $291,348,000.00
  • Revenue This Year
  • AMPH $1.00
  • VRE $6.48
  • Revenue Next Year
  • AMPH $6.74
  • VRE $1.33
  • P/E Ratio
  • AMPH $9.15
  • VRE $23.95
  • Revenue Growth
  • AMPH 1.37
  • VRE 6.39
  • 52 Week Low
  • AMPH $20.39
  • VRE $13.69
  • 52 Week High
  • AMPH $53.96
  • VRE $18.85
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.87
  • VRE 55.41
  • Support Level
  • AMPH $22.94
  • VRE $14.52
  • Resistance Level
  • AMPH $24.87
  • VRE $14.84
  • Average True Range (ATR)
  • AMPH 0.79
  • VRE 0.29
  • MACD
  • AMPH 0.12
  • VRE 0.06
  • Stochastic Oscillator
  • AMPH 42.90
  • VRE 97.04

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

Share on Social Networks: